Patient Perspective on Cross-Linking

Learn more about the importance of early diagnosis and treatment from a keratoconus patient and her treating physician.

A General Overview

Corneal cross-linking is a minimally invasive outpatient procedure that combines the use of Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution) and the KXL® system for the treatment of progressive keratoconus.

Corneal Cross-Linking: A New Standard of Care for Progressive Keratoconus

Corneal collagen cross-linking is an innovative therapy that has transformed the treatment of progressive keratoconus. Historically, as many as 1 in 5 patients with progressive keratoconus have required a corneal transplant, with more than half needing multiple transplants within 20 years.1, 2

¹Pramanik S, Musch DC, Sutphin JE, Farjo AA. Extended long-term outcomes of penetrating keratoplasty for keratoconus. Ophthalmology 2006;113(9):1633-8.
2Maharana PK, Agarwal K, Jhanji V, Vajpayee RB. Deep anterior lamellar keratoplasty for keratoconus: a review. Eye Contact Lens 2014;40(6):382-9.

Top Questions to Ask Your Eye Doctor Download PDF

FDA Approval

The first and only therapeutic products for corneal cross-linking which have been FDA approved to treat progressive keratoconus.

In April 2016, the FDA approved Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5’-phosphate ophthalmic solution) and the KXL® System for corneal cross-linking, a minimally invasive outpatient procedure that combines the use of Vitamin B2 eye drops and ultra-violet (UV) light.

The approval of Photrexa Viscous, Photrexa and the KXL System offers an effective treatment for patients who, until recently, had no therapeutic options to limit the progression of this sight-threatening disease.

Don’t wait to call the eye doctor if you notice changes in your child’s vision! Ask about FDA approved cross-linking, clinically proven to limit the progression of this sight-threatening disease.

Cross-Linking

Learn more about this outpatient procedure

View our Living with Keratoconus Patient Brochure.

Patient FAQs

Discover answers to the most common questions surrounding cross-linking

Visit the Patient FAQ Section to learn more.

Corneal cross-linking provides patients a much-needed option to treat this debilitating disease. Patients suffering from progressive keratoconus can now receive a therapeutic treatment that has been rigorously tested and approved."

Mary Prudden, Executive Director for the National Keratoconus Foundation

What are Patients Saying? View Stories

Learn More Through Our Facebook Page

22 hours ago

Living with KC

Symptoms of #keratoconus can include blurry or distorted vision. What symptoms did you experience before you were diagnosed with KC? ... See MoreSee Less

View on Facebook

2 days ago

Living with KC

Interested in learning more about #keratoconus and treatment options? Visit our website today to learn more. bit.ly/2noX4Ty ... See MoreSee Less

View on Facebook

Learn More Through Our Twitter Page

Have you or a loved one recently been diagnosed with #keratoconus? Visit our website to find a #KCExpert in your area who is performing the only FDA approved therapeutic treatment. https://t.co/f7HBiV9rok

Symptoms of #keratoconus can include blurry or distorted vision. What symptoms did you experience before you were diagnosed with KC?

Interested in learning more about #keratoconus and treatment options? Visit our website today to learn more. https://t.co/YIqqEF1DuA

If you're a new soft contact #lens user, follow @aao_ophth's steps on how to safely & successfully put contacts in your #eyes. https://t.co/5kxGowpN5h

Do you have trouble falling asleep after staring at your phone before bed? Blue light might be the problem! @aao_ophth shares why you should start trying 'night mode' on your phone. https://t.co/Z9XOHdmk8J #LivingWithKC

Load More...

Learn More Through Our Instagram

MA-00687B